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ABSTRACT
Objective: This study explores trends in procurement for 3 hospitals in Connecticut over a fouryear period to better understand how much N2O is released. N2O use and frequency of
conversion to epidural after N2O, as well as emergency cesarean section after N2O use is also
examined. A plan for N2O destruction technology testing is outlined.
Background: Nitrous Oxide (N2O) is a well-documented greenhouse gas (GHG) and ozonedepleting agent. N2O use continues to be unregulated, and concurrently it has also become more
widely adopted for use in labor and delivery in the US, though it has been popular in Europe and
the UK since the 1930’s. A shift in attitudes around labor and birth has resulted in a stronger
desire to avoid “medicalization” of the process; nurse midwives and other healthcare providers
that are qualified to administer N2O can do so and prevent anesthesiologist intervention. The use
of N2O to replace epidural is sometimes mischaracterized as a “natural” pain management
strategy. As a potent GHG that is gaining popularity, it is important that use is more actively
monitored and regulated by hospitals, as well as adopting technologies to prevent untreated
release of N2O into the atmosphere.
Methods: N2O procurement data was analyzed over a four-year period. Conversion to CO 2
equivalents was made using the global warming potential multiplier established by the
Intergovernmental Panel on Climate Change (IPCC). Five hospitals were analyzed for N 2O
Conversion (or “failure”) over one calendar year (2019). This data was also used to assess
whether parturients were at higher risk of emergency cesarean section after N 2O use.
Results: N2O use in 3 hospitals within the Yale New Haven Health System (YNHHS), has
increased by 99.3% over a four-year period, and is likely to continue increasing, if the patients
2

and providers continue to prefer its use over epidurals. 42% of parturients (n=784) receiving N 2O
during labor went on to also receive neuraxial pain management. 3% of patients receiving N 2O
during a labor attempt went on to require emergency cesarean section. N 2O use for pain
management is associated with no increased relative risk of emergency cesarean section
(RR=0.99). However, conversion from N2O to neuraxial pain management is associated with a
4.5-fold increased risk for emergency cesarean section.
Conclusions: Higher selectivity for N2O use could reduce overall GHG emissions, without
sacrificing patient outcomes. US hospitals could decrease their N 2O emissions by installing N2O
destruction units. A sample test outline for independent verification of N 2O destruction
technology is outlined in this study, both in a trial and hospital setting.
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INTRODUCTION
One of the most pressing public health issues of our time is climate change, which
exacerbates an array of health risk factors, including air quality, housing insecurity, food scarcity
and infectious diseases1. The healthcare industry is a major contributor to global greenhouse gas
(GHG) emissions, and accounts for nearly 10% of the national total emissions annually in the
US2. In addition to GHGs emitted indirectly from hospitals in the form of energy required to heat
or cool facilities, power technology, run tests as well as upstream emissions from supply chain
manufacturing and downstream waste disposal, healthcare facilities directly release GHGs in the
form of waste anesthetic gases (WAGs)3. Hospitals using Nitrous Oxide (N 2O) have protocols in
place for proper indoor ventilation, and prevention of occupational exposure. However, these
protocols often only go so far as removing the nitrous oxide from patient breathing circuits,
venting waste gas outside without further treatment.
Nitrous oxide was popularized as an anesthetic in 1868, beginning with dental patients. It
has a long history of use in delivery rooms for analgesia for laboring mothers. It remains popular
across Europe, including in the UK1, though fell out of favor in the US when neuraxial (spinal
and epidural) analgesia performed by anesthesiologists became more readily available. In recent
years, however, N2O has reemerged as a popular alternative to neuraxial pain management in the
US2, driven largely by nurse midwives whose scope of practice allows them to use it
independently of physician oversight. N2O , like all inhaled anesthetic gases are known to be
GHGs3. N2O also depletes the ozone layer once it makes its way to the stratosphere 4, with an
ozone depleting potential (ODP) of 0.017 5. N2O release from hospitals is not regulated anywhere
in the world—the European Commission currently has an opt-in system for controlling N 2O
6

release in hospitals6, and a cap for N2O emitted by power plants and factories7. Additionally, it is
a potent GHG, with a global warming potential (GWP) 298 times more potent than CO 28. In
2017, N2O (including non-medical sources) accounted for 6.5% of US total GHG emissions 9.
Because of its persistence in the atmosphere and it’s high infrared trapping properties, the total
amount of N2O in the atmosphere today is equivalent to 1/3 of the total CO 2, in terms of
warming potential10. As the human population continues to grow and industry grows with it,
these numbers also continue to grow5. Although a large portion of N2O emissions can be
attributed to agriculture, waste water treatment and burning of fossil fuels, the contributions from
anesthesia should not be ignored. N2O that is released today is estimated to remain in the
atmosphere until 21341,2 with an atmospheric lifetime estimated to be around 114 years 12.
Anesthetic waste is thought to contribute around 0.0005% of all ozone depletion as of the early
1990’s13, however, as other ODPs were limited by the Montreal Protocol, N 2O emerged as the
largest single contributor to ozone depletion, and is expected to remain so for the remainder of
the 21st century.5
Though seen as a promising and sometimes “natural” alternative to other pain
management strategies, with a majority of women electing N 2O citing preference for a
“nonmedical” birthing experience15, literature shows that 40-63% of women requesting only N 2O
for pain management at labor onset went on to request an epidural 16,15 meaning N2O analgesia
was not a sufficient method of pain management for a significant fraction of patients. This
suggests that N2O should be used by healthcare practitioners more selectively, however no study
to date has investigated what conditions lead to greater probability of successful N 2O analgesia.
Given the limited effectiveness of N2O, understanding under what circumstances N2O may not
be the best analgesic choice may not only benefit patients, but may also be a method by which
7

healthcare providers can limit WAG pollution. Teasing out factors to aid better selection is
complex, however, as it involves elucidating behavioral and communication factors for both
patients and staff alike.
Though medical sources of N2O are only a portion of global GHG emissions,
practitioners and hospital administration should be proactive in limiting WAG release into the
atmosphere in an effort to improve environmental health, and also to reduce occupational
exposure. Current guidelines in N2O use by medical professionals, including ventilation
protocols and WAG scavenging systems may be insufficient in limiting this release. Hospitals
should be treating their waste anesthesia, as they manage other forms of waste. The National
Institute for Occupational Safety and Health (NIOSH) recommends that hospitals vent WAGs
out of the operating room and into an area where people will not unintentionally breathe the
gases. They also recommend that anesthesia machines and breathing circuits are carefully
monitored to minimize leaks, and to carry out gas chamber refills before or after the procedure
and under a chemical hood14. This means that hospitals vent waste N2O collected into a breathing
circuit and vent WAG through a scavenging system to the outdoor environment. While these
protocols are necessary for preventing workplace exposure to anesthetics, they do little to protect
the public health.
In addition to more selective use, WAG collection systems offer another opportunity for
emissions prevention. A crucial step in eliminating WAG pollution is the use of scavenging
systems, which are connected directly to anesthesia machines, and treat exhaled WAG before the
hospital’s vacuum system removes the WAG from the breathing circuit. The need for effective
scavenging systems to avoid high indoor occupational exposures to anesthetics have long been
known. In the context of labor and delivery, proper breathing technique of exhaling N 2O back
8

into the mask becomes difficult because of the pain with contractions. Women often do not
exhale through the breathing circuit, and the WAG is not scavenged. Though WAG systems do
improve indoor air quality, some N2O can still remain present, and rooms must have a high
degree of ventilation. Healthcare providers and bioengineers are often dealing with issues of
leaking systems and administration technique in order to minimize this exposure 17. Presently,
scavenging systems simply vent waste N2O off to hospital rooftops to the outdoor environment 5.
While this is thought to reduce occupational exposure, there is evidence that improved
ventilation alone does not bring ambient N2O concentrations into the 25ppm range, as
recommended by OSHA, and one study found that more than 40% of test sites in clinical rooms
had N2O concentrations exceeding NIOSH recommendations10, even after patients were coached
on proper breathing techniques that would limit ambient release. This is concerning for
healthcare workers because repeated N2O exposure is associated with chromosomal changes and
increased risk of spontaneous abortion18. WAG treatment is an important step in the right
direction, but more progressive measures can be implemented to eliminate WAG. N 2O
destruction systems have been widely implemented in Sweden, and in some parts of the UK.
They use photolysis to break N2O to diatomic nitrogen and oxygen19,20.
In addition to leaky systems, occupational exposure limits can be reached or exceeded
when N2O units are improperly used by patients. Systems used for adults generally have a
handheld mask, which patients are instructed to create an airtight seal, inhale through the nose or
mouth, and then exhale the N2O back into the mask21. The exhaled N2O then flows into a
scavenging system located on the unit. During labor and delivery, patients are often in pain and
forget or are unable to properly exhale the N2O into the mask, even with coaching.
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Healthcare providers in labor and delivery units are generally unaware of the greenhouse
gas properties of N2O , however many offer it as an analgesic without fair consideration for
alternatives such as epidural anesthesia due to desires to keep control of the birthing process
outside of anesthesiologist involvement 16. Its anxiolytic property is especially important in the
context of labor and delivery because anxiety is known to increase perceptions of pain 22.
Reductions in anxiety during labor and delivery have been observed while using N 2O 23. N2O is
thought to exert its effects via endorphin release24, but the exact mechanism is unknown25. One
provider noted that effective coaching is essential if parturients request N 2O -only analgesia
during delivery, but further research on coaching techniques is required.

Summary of Project Aims
The ultimate goal of this study is not to discontinue or discourage the use of N 2O by
healthcare practitioners, but to help us understand the ways in which it can be used that limit its
impacts as a greenhouse gas. This study is intended to lay the groundwork for future work that
will help healthcare providers to strategically use N 2O for appropriate patients. In a time when
we are struggling to hold on to the progress made by environmental activists, justice advocates
and sensible policy, this study aims to move power over emissions from policymakers into the
hands of healthcare providers.
Aim 1: Determine greenhouse gas emissions of N2O from 3 hospitals in the Yale New
Haven Health System.
By tracking N2O procurement over a 4-year period, this study aims to inform the hospital
sustainability program on the system’s N2O use, as well as approximate the total N2O emissions
from that system. Understanding trends in use is informative, but has not been tracked in this
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particular health system, the Yale New Haven Hospital Health system (YNHHS). Like YNHHS,
many other hospitals in the US do not track N 2O emissions or procurement.
Aim 2: Characterize the use of N2O in the context of labor and delivery, and quantify N 2O
conversion to neuraxial pain management in 5 hospitals in the Yale New Haven Health
System.
This project aims to characterize the nature of patient utilization of N 2O the context of labor
and delivery, specifically to better understand the frequency of use, and conversion from nitrousonly pain management to epidural or other methods of pain management. Understanding what
factors affect parturients who request only N2O analgesia ultimately choose to convert to
neuraxial pain management, or continue with N2O can help healthcare providers to strategize
their use of N2O.
Aim 3: Create a test protocol to determine the efficacy of N 2O destruction technologies.
For patients and providers who continue to use N2O, proper procedures for treatment and
release of N2O waste should be applied. Just as healthcare providers have methods for disposal
and treatment of everything from biohazardous materials, pharmaceuticals, sharps, universal and
municipal solid waste, N2O waste disposal should be treated as well. N2O destruction
technologies, such as photolytic treatment to convert N 2O to diatomic oxygen and nitrogen are
thought to be as efficient as 99%20. This thesis includes a plan for independent verification of
commercially available N2O destruction technology efficiency, as well as suggestions for
implementation in clinical use.
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METHODS
Yale New Haven Hospital N2O Procurement Data
According to the Intergovernmental Panel on Climate Change (IPCC), every 1kg N 2O
released into the atmosphere is equivalent to releasing 298 kg of CO 2 into the environment26, in
terms of its warming potential. Global warming potential (GWP) measures the amount of heat
any given GHG traps in the atmosphere, in comparison to CO 2, over a period of 100 years9. As
this drug is not metabolized, all drug delivered to the patient is exhaled or otherwise wasted
unused, and vented directly to the outdoor environment. Thus, data on procurement is typically
used to estimate the amount of drug released over the same period.
Procurement data was provided by Yale New Haven Health Services Corporation, giving
a complete record of anesthetic gases purchased by Yale New Haven Health Services Center.
Vendor information captured in the data was used to calculate the total amount of N 2O in each
type of tank, and then multiplied by the number of tanks ordered. Total N 2O was converted from
pounds to kilograms, then into CO2-equivalents using the IPCC multiplier of 298. Data was
categorized by year, and included 2016, 2017, 2018 and 2019. Data from years 2020 and 2015
were excluded because datasets were incomplete.
YNHHS N2O use in labor and delivery
Data provided by Yale New Haven Hospital System reporting labor and delivery ward
location, year, delivery type (vaginal vs. cesarean section), anesthesia method, birth outcome,
whether there was a labor attempt before cesarean (to classify emergency cesarean section), and
number of babies delivered was used to determine conversion rate from nitrous oxide to epidural,
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as well as whether parturients who were administered N 2O were at elevated risk of emergency
cesarean by calculating relative risk. A data cleaning protocol can be found in Appendix C.
The total number of parturients who received N2O only was compared to number of
parturients receiving N2O and epidural. That group was analyzed to find the number of
parturients who went on to have an emergency cesarean section.
Testing Scenario for N2O Destruction Technology
As outlined in the introduction, scavenging systems for WAG are an essential step
towards eliminating GHG emissions from hospital systems. The current ventilation systems
commonly used in the US are not acceptable. Scavenging systems are generally located on
anesthesia machines, and remove WAG from the patient breathing circuit, preventing it from
leaking out into the room. While this is a necessary component of anesthesia use, it does generate
waste which needs to be destroyed or stored. Ventilation systems are also required to protect
healthcare staff from occupational exposure to WAG. Generally, this consists of a normal
heating, ventilation and air conditioning (HVAC) systems that move air and maintain
comfortable room temperature. Adopting WAG destruction technologies and making them
commonplace in the hospital is the most effective method to mitigate both the problem of WAG
release, and eliminates the need to store WAG.
Use of N2O destruction technologies are widely used in Sweden. Unpublished data from
Region Stockholm shows that installing N2O destruction units in its 7 hospitals led to major
decreases in N2O emissions, as shown in table 1. Resources for reducing total amount of N 2O
released are available to healthcare providers. These resources include guides for proper mask
technique, or even altering N2O flow for maximum impact at strategic times27. General
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awareness among this population that N2O is a potent GHG may contribute to successes in GHG
reductions seen in hospitals in Sweden.
Year
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018

N2O Procured N2O Destroyed
23,374
2,410
23,866
4,929
23,685
7,726
24,940
7,726
NA
NA
NA
NA
NA
NA
NA
NA
21,296
12,653
21,560
12,847
22,058
12,669

Total Emitted
20,964
18,937
15,959
17,214
9,654
11,638
10,690
8,556
8,643
8,713
9,390

Table 1: Region Stockholm was able to reduce total N2O emissions by 123.3% over a 10-year
period by implementing N2O destruction technologies in its 7 hospitals. This data and analysis
were provided by Johanna Borgendahl, for Region Stockholm.

Figure 1: Medclair Mobile Destruction Unit.
Implementing this technology would be relatively easy in hospitals in the US. Several
types of systems are available, including rooftop units which serve an entire hospital’s N 2O
WAG, as well as mobile units which can be used with one patient at a time. For the purposes of
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testing this technology in this particular setting, a guide to installation and testing of Medclair’s
Mobile Destruction Unit (MDU) (shown in figure 1) will be outlined.
This technology is marketed and used primarily in Europe, so use of a converter and
proper power outlet is required. Any room with 230V outlet is suitable for testing this
technology. If the MDU is found to be suitable for widespread use, speaking with Medclair or
other manufacturers about making the MDU compatible with 120V power would be important.
The room must also be equipped with an anesthesia machine, with a built-in spectrophotometer.
The testing room should also be available for at least 1 full day at a time for testing—that is, no
patients of healthcare workers should need to use that room while the MDU is being tested. This
room should be selected in collaboration with staff and administrators, who will be able to
identify out-of-the-way locations for testing sites.
The primary N2O system used for labor and delivery at Yale New Haven Hospital is the
Nitronox System21. This provides patients with a 50% N2O, 50% O2 mixture, administered via
demand valve, as shown in figure 2. The masks used with this system are handheld, rather than
strapped to the nose and mouth, meaning that gas is only released when the patient holds the
mask to their face to create an airtight seal, and inhales purposefully. Before N 2O is given to
patients, they are told to exhale back into the mask, so that waste N 2O can be removed from the
breathing circuit and put into the Nitronox scavenging system.
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Figure 2: Nitronox System used at YNHH & functional schematic.
Test Scenario:
In order to test the N2O destruction technology, some modifications need to be made to
the MDU. N2O WAG is taken into Gas Inlet #1, shown in figure 1, and clean, filtered air exits
the machine through a vent underneath the MDU. The vent cover should be removed, and a
spectrophotometer inlet tube placed at the base of the orange tube, where cooled, clean air exits
the photolysis chamber. Plumbers tape should be effective, and would not off gas any volatile
compounds that may alter spectrophotometer readings. A sheet of plastic should be taped over
the vent space, making it airtight, and securing the spectrophotometer inlet in place. An ideal
material for this plastic sheeting would be a trash bag, which has enough volume to balloon and
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accommodate emission of treated N2O air, without building up pressure and altering the function
of the MDU. On one end of the trash bag, a puncture should be made, and a tube placed through
the hole. Tape should be used to make the balloon air tight. The tube can then be connected to
the connection for the scavenging system on the anesthesia machine, as shown in figure 3. A
second spectrophotometer inlet should be attached to the N 2O mask, in order to read N2O
concentrations in exhaled air.

Figure 3: Basic layout of an anesthesia machine.
With the MDU fully set up, readings can begin. Ideally, a volunteer could agree to inhale
N2O and exhale it through the machine. However, recruiting a volunteer and obtaining IRB
approval is logistically difficult, and the MDU can also be tested without any human
participation. A breathing bag can be attached to the N 2O unit respirator with tape to simulate
17

breathing. Readings for inhaled and exhaled N2O can determined based on peak CO2
concentrations, as reported by the anesthesia machine. Because there will be no CO 2 production
in a test scenario with no human volunteer, it will be difficult to differentiate a simulated
“inhale” from the simulated “exhale” as the N2O concentration will remain steady. In practice,
high relative CO2 concentration indicates an exhale, while low relative CO 2 concentrate indicates
an inhale, and these concentrations are used in an algorithm to differentiate inhaled
concentrations of N2O from exhaled concentration of N2O. Time stamps should be used to
demarcate the simulated inhalations and exhalations to determine the N 2O concentrations within
the breathing circuit.
Readings at the breathing circuit and the MDU exhaust should be taken every minute
over a 1-hour period at several clinically-relevant flow rates. Most systems recommend a flow
rate of 45 liters/minute, but a few flow rates above and below that level should be tested, since
some systems allow alterations in flow rate. Flow rates of 40, 45, 50 and 55 liters per minute can
be tested using an anesthesia machine. Several N2O concentrations can also be used. Some N2O
systems do not allow providers to alter the concentration from a 50/50 mix for safety reasons, but
others do. Providers in Sweden are known to use concentrations as high at 70% N 2O during
labor28. Testing the MDU with 50%, 60% and 70% N 2O at each of the 4 flow rates could provide
useful information on the optimal flow rates for N 2O destruction for all concentrations.
If readings of emitted air are acceptable with the 99% of N 2O destroyed, the MDU can be
evaluated by policymakers for use in a clinical setting with patients. MDU use in a real hospital
setting will reduce the overall amount of N2O destroyed compared to test scenarios because
patients in labor frequently exhale N2O outside of the mask. Before implementing N2O
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destruction technologies, supplemental studies could take N2O readings in the room, using an
N2O monitor independent of the anesthesia machine.

RESULTS
N2O Procurement data
N2O purchased throughout the system has increased steadily over the past four year, as
shown in figure 4. CO2 equivalents of N2O grew from 2,206,998.0 kg CO2 in 2016 to
4,123,068.4 kg CO2 in 2019, shown in table 2. Total N2O procurement does not account for all
facilities within the health system—N2O for the Saint Rafael Campus and Greenwich Hospital
are not purchased through the centralized system. Much of the total N 2O procurement for
YNHHS came from its largest hospital, Yale New Haven Hospital (YNHH), as shown in Figure
5. While YNHH has grown steadily, contributing much to the overall health system’s
procurement growth, Lawrence Memorial Hospital’s (LMH) procurement has more than doubled
over a four-year period, as shown in figure 6. Bridgeport Hospital’s (BH) procurement has
decreased, as shown in figure 7.
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Figure 4 Total overall procurement of N2O has increased steadily over the recent 4 years.

Table 2: Total N2O purchased by Yale New Haven Health System. CO 2 equivalents of N2O
released by the system as a whole have increased by 86.8% from 2016 to 2019. The conversion
was calculated by multiplying N2O purchased in kilograms by 298, the IPCC GWP conversion
factor.
20

Figure. 5: Yale New Haven Hospital, the largest facility accounts for much of the total N 2O
procurement.

Year
2016
2017
2018
2019

Yale New Haven Hospital
N2O Purchased (kg) CO2 Equivalents (kg)
6.3E+03
1.9E+06
6.3E+03
1.9E+06
8.7E+03
2.6E+06
1.3E+04
3.8E+06

Table 3: N2O procurement rose by 99.3% between 2016 and 2019.
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Figure 6: Total N2O procured has remained relatively steady at Bridgeport hospital. Procurement
fell by less than 1% in 2017, increased by 27% in 2018 and fell by 42% in 2019.

Year
2016
2017
2018
2019

Bridgeport Hospital
N2O Purchased (kg) CO2 Equivalents (kg)
7.5E+02
2.2E+05
7.5E+02
2.2E+05
9.5E+02
2.8E+05
5.5E+02
1.6E+05

Table 4: N2O purchased at Bridgeport Hospital fell by 27% between 2016 and 2019.
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Figure 7: Lawrence Memorial Hospital’s N2O procurement has been variable over the recent
years. It rose by 113% in 2017, 27% in 2018 and fell by 24% in 2019.

Year
2016
2017
2018
2019

Lawrence Memorial Hospital
N2O Purchased (kg) CO2 Equivalents (kg)
3.3E+02
9.9E+04
7.1E+02
2.1E+05
8.9E+02
2.7E+05
6.8E+02
2.0E+05

Table 5: Total N2O Purchased by Lawrence Memorial Hospital. Though there has been
variability in N2O procurement, it still grew by 105% between 2016 and 2019.
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N2O conversion and labor history
Data on labor history and method of analgesia from Yale New Haven Hospital,
Bridgeport Hospital, Greenwich Hospital, Lawrence Memorial Hospital, and Saint Rafael
Campus Hospital in 2019 showed that of parturients across all labor and delivery units
(n=11,885), 6.6% of parturients elected N2O during labor (n=784). 42% of those patients
(n=329) went on to also receive neuraxial pain management, shown in figure 8. The conversion
rate from N2O to neuraxial pain management ranged from 37% at LMH to 44% YNHH and
SRC. GH did not record any parturient use of N2O, and uses almost exclusively neuraxial pain
management for delivery. Bridgeport hospital reported a 40% conversion rate.
When looking at N2O use in emergency cesarean sections, 7% of parturients are
administered N2O before a delivery attempt is made. The relative risk of emergency cesarean
section after N2O use is 0.99, as shown in table 8. However, N2O conversion is associated with a
4.5-fold increase in risk of emergency cesarean section, shown in table 9. This population
(n=12105) excluded parturients with planned c-sections.

Figure 8: 322 of total parturients (n=784) using N 2O across all Yale New Haven Health System
hospitals went on to receive neuraxial pain management as well.
24

Figure 9: N2O conversion to neuraxial pain management accounted for 37-44% of all N 2O use
across all hospitals. YNH= Yale New Haven, BH= Bridgeport Hospital, GH= Greenwich
Hospital, LMH= Lawrence Memorial Hospital, SRC= YNHH Saint Rafael Campus

Hospital

Total N2O

YNH
BH
GH
LMH
SRC
All Hospitals

377
5
0
73
329
784

N2O Conversion to
Neuraxial
167
2
0
27
136
332

Conversion Rate
44%
40%
NA
37%
44%
42%

Table 6: 37-40% of parturients using N2O went on to request neuraxial pain management as well.
Greenwich Hospital did not administer N2O to any parturients, so a conversion rate was not
calculated.
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Figure 10: N2O was administered to few parturients who went on to require emergency cesarean
section. 100% of patients who used N2O during labor attempt and later needed emergency csection had neuraxial pain management.

Clinic
YNH
BH
GH
LMH
SRC
Overall

Total Emergency Csections
65
25
28
10
10
138

Emergency C-sections
with N2O
6
0
0
0
4
10

Table 7: 7% of parturients who require emergency cesarean section are given N 2O during
delivery attempt.
26

N2O administered
No N2O
total

Emergency Cesarean
10
141
151

Non-emergency Birth
853
11101
11954

Total
863
11242
12105

Table 8: Relative risk of emergency cesarean section after N 2O use was 0.99.

Emergency Cesarean

Non-emergency Birth

Total

N2O Conversion to
Neuraxial Pain
Management

10

322

332

N2O-only pain
management

3

449

452

total

13

771

748

Table 9: Relative risk of emergency cesarean section after N 2O conversion was 4.5.

DISCUSSION
Overall procurement of N2O has increased over a four-year period, totaling to 86.6%
growth since 2016. The total N2O released since 2016 by YNHHS is equivalent to 11,799,518 kg
of CO2. In terms of its warming potential this is equivalent to 13,001,451 pounds of coal burned,
or 1,327,728 gallons of gasoline used. Further research is needed in tracking how many units of
N2O are delivered to different areas of the hospital. It would also be helpful to have a centralized
system for tracking anesthetics (or any GHGs) across the entire health system, rather than the
current piece meal system of procurement. The current systems at YNHHS only serve to keep
27

workers safe and healthy by venting N2O WAG outside of the patient rooms it is being used in.
This relatively small proportion of GHG emissions from this single source becomes suddenly
large when looking at its GWP. With increasing popularity among nurse midwives, and doulas,
N2O procurement is likely to grow in the coming years if the desire for a “nonmedical” birth
remains popular among parturients. YNHH as a community hospital has a responsibility to
maintain the health and safety of people from all backgrounds. It is well-documented that climate
change will exacerbate existing health disparities. Therefore, immediate implementation of
scavenging systems, and a shift to N2O destruction technologies is of high importance.
In 2019, 44% of parturients in the 5 YNHHS hospitals receiving N 2O during labor went
on to have neuraxial pain management. 6.6% of parturients elected N 2O during labor in this
study. While N2O use does not confer any elevated risk of emergency cesarean, N 2O conversion
was associated with a 4.5-fold increased risk of emergency cesarean section compared to
parturients that did not convert to neuraxial pain management. Deeper understanding of how
providers choose to administer or not administer N 2O to parturients can help us understand if this
effect is because healthcare providers choose to administer N 2O to high-risk pregnancies, like
parturients with gestational diabetes, chronic kidney disease, preeclampsia, high blood pressure
or high maternal age. The high likelihood of neuraxial anesthesia after N 2O demonstrates a need
for more selective N2O use, as well as install systems to effectively destroy any N 2O that is used.
Further research is required on the coaching techniques used by nurse midwives, OBGYNs, and
other healthcare providers for women preparing to give birth.

28

Limitations
Portions of this study were cancelled due to COVID-19. Information on N 2O
procurement data was limited to only 3 hospitals in the Yale New Haven Health system, making
it difficult to understand N2O use in certain hospitals. Procurement data for SRC was
unavailable, which had the second-largest number of total parturients using N 2O. Procurement
data for GH, which did not administer N2O to any parturients in 2019 was also unavailable—this
study cannot determine if no N2O was administered due to strict selectivity, or if it was simply
not available to patients.
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C: Data cleaning & editing protocols:
N2O Procurement data:
The original dataset included all orders of anesthetics, gases and other materials. The
excel page containing raw data in the form of line items was copied and pasted into a new blank
document. In order to capture only N2O procurement, the “item description” column was
searched using CTL+F for “nitrous oxide” and “N 2O”. Rows that did not contain N2O
procurement information were deleted.
New columns were created for calculating the total weight of N 2O. The “item
description” column and “vendor” column were used to figure out the total amount of N 2O
ordered in each row. This information came from the vendor websites, and the weight of N 2O in
lbs was added to each row. A new column was added to convert lbs to kg. The “units rqd”
column contained information on the number of units ordered. A new column for the total N 2O
weight was added, and row values were found by multiplying the weight of each item in kg by
the number of units ordered.
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The new excel sheet was converted to a comma delimited file and moved to R for
analysis.
N2O Conversion and Labor History
The original OB History dataset arrived with a column containing a list of anesthetics that
each patient received. The dataset was copied and pasted into a new blank document. It did not
contain any patient information, but the “patient ID” column was deleted for highest precaution.
New blank columns were created for each type of anesthetic, and each patient was assigned “Y”
if they received the drug or “N” if the drug was not included in the original list.
The new excel sheet was converted to a comma delimited file and moved to R for
analysis.
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